Bio-Rad Laboratories, Inc. develops, manufactures, and markets a broad range of products and solutions for the life science research and clinical diagnostics markets. Technologies and applications include electrophoresis, imaging, multiplex immunoassay, chromatography, microbiology, protein function analysis, transfection, flow cytometry and cell sorting, amplification, and real-time and digital PCR.
Bio-Rad is an in-vitro diagnostics supplier, delivering a large portfolio of innovative products to clinical laboratories worldwide. Also the Company is a leader in clinical quality control products, services, and information systems. These products ensure the accuracy and validity of clinical test results and are used by more clinical laboratories than products from any other company. Its other diagnostic products and systems leverage a broad range of technologies and deliver high-value clinical 
information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets and are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions.

Company Growth (employees)
Type
Public
HQ
Hercules, US
Founded
1952
Size (employees)
8,250 (est)
Bio-Rad was founded in 1952 and is headquartered in Hercules, US

Bio-Rad Office Locations

Bio-Rad has an office in Hercules
Hercules, US (HQ)
1000 Alfred Nobel Dr
Hercules, US
4000 Alfred Nobel Dr
Hercules, US
2000 Alfred Nobel Dr

Bio-Rad Financials and Metrics

Bio-Rad Financials

Bio-Rad's revenue was reported to be $2.1 b in FY, 2016
USD

Revenue (Q2, 2017)

504.7 m

Gross profit (Q2, 2017)

273.3 m

Gross profit margin (Q2, 2017), %

54%

Net income (Q2, 2017)

17.4 m

Market capitalization (13-Nov-2017)

7.6 b

Cash (30-Jun-2017)

321.6 m
Bio-Rad's current market capitalization is $7.6 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

2.1 b2.2 b2 b2.1 b

Revenue growth, %

2%(7%)2%

Cost of goods sold

897.8 m930.1 m

Gross profit

1.1 b1.1 b
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

505.1 m509.3 m536.8 m530.6 m472.8 m506.1 m470 m471.2 m516.8 m508.7 m500.1 m504.7 m

Cost of goods sold

220.9 m234.1 m239.6 m242.1 m202.7 m226.5 m206.5 m207.2 m236.5 m229.3 m230.1 m231.4 m

Gross profit

284.2 m275.3 m297.2 m288.6 m270.1 m279.6 m263.5 m264 m280.2 m279.5 m270 m273.3 m

Gross profit Margin, %

56%54%55%54%57%55%56%56%54%55%54%54%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

331.6 m413.3 m457.5 m456.3 m

Inventories

525 m

Current Assets

1.7 b1.7 b1.8 b1.8 b

PP&E

429.4 m428.8 m437.7 m488.6 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

291.8 m364.5 m384.7 m424.6 m425.7 m450.1 m507.3 m403.6 m418.7 m417.9 m291.7 m321.6 m

Accounts Receivable

383.5 m383.9 m378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m392.8 m

Inventories

523.5 m513.9 m520.6 m516 m478.4 m501 m512.7 m533.3 m541.5 m556.4 m559.8 m580.6 m

Current Assets

1.7 b1.8 b1.8 b1.8 b1.7 b1.7 b1.8 b1.8 b1.8 b1.9 b1.7 b1.8 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

77.8 m88.8 m113.1 m

Cash From Operating Activities

175.5 m273.3 m186.2 m216.4 m

Capital Expenditures

(113 m)(121 m)(112 m)(141.4 m)

Cash From Investing Activities

(5.4 m)(190.5 m)(166.9 m)(213.9 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

31.6 m11.5 m17.8 m28.4 m17.4 m12.3 m30.3 m48.7 m12.4 m

Accounts Receivable

378.9 m354.4 m342.2 m354.2 m341.5 m381.1 m366.3 m367.7 m373.4 m

Accounts Payable

125.5 m126.6 m
Y, 2017

Financial Leverage

1.5 x
Show all financial metrics

Bio-Rad Market Value History

Bio-Rad's Web-traffic and Trends

Bio-Rad Online and Social Media Presence

Bio-Rad Company Life and Culture

You may also be interested in